CAVA Group, Inc.CAVA

Why is CAVA Group (CAVA) moving?

Q3 202615 Jul – 27 Sep 2026

▲3▼1

CAVA beats Q2, launches buyback, but rich valuation and outbreak risks linger

Q2 earnings beat and guidance affirmed CAVA reported 9% same-restaurant sales growth, 31.3% revenue growth, and higher customer traffic, beating estimates and affirming full-year guidance. The company also opened 17 net new restaurants, showing continued expansion.
This is the core positive fundamental news that drove the stock during the period.
Morgan Stanley upgrade and fading cyclospora fears Morgan Stanley upgraded CAVA, and concerns about the cyclospora outbreak that had pressured sales and the sector began to fade. This shift in sentiment helped lift the stock.
Analyst upgrade and easing of a specific risk are key catalysts for the stock's performance.
$100 million buyback announced CAVA announced a $100 million share buyback, backed by strong cash flow, no debt, and growing loyalty. This signals confidence and returns capital to shareholders.
Buyback is a new capital allocation move that supports the stock price.
Rich valuation and growth dependence Despite strong results, CAVA trades at a very rich 90.9 times earnings, leaving little room for error. Growth depends on continued new-store expansion, making it vulnerable to any quarterly wobbles.
This is the main counterweight and risk that could pressure the stock.

September 202613 Aug – 27 Sep 2026

▲3

CAVA's strong Q2 growth meets food-safety drag and a new buyback

Cyclospora outbreak hit fresh-produce demand, but sales have rebounded A lettuce-linked cyclospora outbreak scared customers away from salads, denting CAVA's late-Q2 sales and pushing Sweetgreen to cut its outlook. CAVA's CFO said same-restaurant sales have since recovered to the mid single digits, so the damage looks temporary rather than a lasting change in how people eat.
Explains the main negative force on CAVA this period and whether it is fading.
Q2 results showed 9% same-store sales growth on higher traffic CAVA reported revenue up 31.3% to about $368 million, 9% same-restaurant sales growth and 5.3% more customer visits, with profit of $0.19 per share. More people coming through the doors, not just higher prices, is the healthiest kind of growth and supports the expansion story.
The quarter's core numbers are the fundamental driver behind the stock's direction.
Newer restaurants and loyalty members are fueling growth CAVA's 2024 store class is its best-performing ever, new locations beat 100% of expected productivity, and its loyalty base is growing faster than store count. Management plans 75-77 net new restaurants in 2026, which keeps revenue compounding even if any single quarter wobbles.
Shows the growth engine behind CAVA's long-term value, not just one quarter.
Strong cash flow and a new $100 million buyback CAVA generated $44.8 million of free cash flow in the first half, has $435.6 million in cash and no debt, and announced a $100 million share buyback through 2027. Buying back stock lifts earnings per share, though the shares still trade at a very rich 90.9 times earnings.
Capital returns and balance-sheet strength are a fresh, concrete support for the stock.

Latest13 Aug – 27 Sep 2026

▲3

CAVA's strong Q2 growth meets food-safety drag and a new buyback

Cyclospora outbreak hit fresh-produce demand, but sales have rebounded A lettuce-linked cyclospora outbreak scared customers away from salads, denting CAVA's late-Q2 sales and pushing Sweetgreen to cut its outlook. CAVA's CFO said same-restaurant sales have since recovered to the mid single digits, so the damage looks temporary rather than a lasting change in how people eat.
Explains the main negative force on CAVA this period and whether it is fading.
Q2 results showed 9% same-store sales growth on higher traffic CAVA reported revenue up 31.3% to about $368 million, 9% same-restaurant sales growth and 5.3% more customer visits, with profit of $0.19 per share. More people coming through the doors, not just higher prices, is the healthiest kind of growth and supports the expansion story.
The quarter's core numbers are the fundamental driver behind the stock's direction.
Newer restaurants and loyalty members are fueling growth CAVA's 2024 store class is its best-performing ever, new locations beat 100% of expected productivity, and its loyalty base is growing faster than store count. Management plans 75-77 net new restaurants in 2026, which keeps revenue compounding even if any single quarter wobbles.
Shows the growth engine behind CAVA's long-term value, not just one quarter.
Strong cash flow and a new $100 million buyback CAVA generated $44.8 million of free cash flow in the first half, has $435.6 million in cash and no debt, and announced a $100 million share buyback through 2027. Buying back stock lifts earnings per share, though the shares still trade at a very rich 90.9 times earnings.
Capital returns and balance-sheet strength are a fresh, concrete support for the stock.

July 202615 Jul – 12 Aug 2026

▲3▼1

CAVA beats Q2 estimates as cyclospora fears fade, analyst upgrade lifts stock

Morgan Stanley upgrade Morgan Stanley upgraded CAVA to overweight, calling it one of the strongest fundamental stories in restaurants. An upgrade from a major bank signals confidence in the business and draws new investor attention, pushing the stock up.
This is a new analyst endorsement that directly lifted CAVA shares and frames the bull case.
FDA cyclospora outbreak investigation The FDA investigated a cyclospora outbreak that hit the fast-casual sector, dragging CAVA and Sweetgreen down. Health scares scare customers away and raise uncertainty, so the stock fell until the issue eased.
This was the main negative force on CAVA during the period and explains the earlier drop.
Q2 earnings beat and guidance affirmed CAVA beat second-quarter revenue and earnings estimates, with same-restaurant sales up 9% and adjusted EBITDA up 30%. It opened 17 net new restaurants and affirmed full-year guidance, showing the growth story is intact and pushing the stock sharply higher.
The earnings beat is the biggest new positive catalyst and confirms the company's fundamentals.
Cyclospora headwinds moderating Jefferies said quarter-to-date trends were better than feared, with cyclospora-related weakness bottoming in mid-to-late July before same-restaurant sales recovered toward mid-single-digit growth. Fears easing removes a cloud over the stock and supports the rebound.
This explains why the earlier negative health-scare pressure reversed and the stock jumped.

15 Jul – 12 Aug 2026

▲3▼1

CAVA beats Q2 estimates as cyclospora fears fade, analyst upgrade lifts stock

Morgan Stanley upgrade Morgan Stanley upgraded CAVA to overweight, calling it one of the strongest fundamental stories in restaurants. An upgrade from a major bank signals confidence in the business and draws new investor attention, pushing the stock up.
This is a new analyst endorsement that directly lifted CAVA shares and frames the bull case.
FDA cyclospora outbreak investigation The FDA investigated a cyclospora outbreak that hit the fast-casual sector, dragging CAVA and Sweetgreen down. Health scares scare customers away and raise uncertainty, so the stock fell until the issue eased.
This was the main negative force on CAVA during the period and explains the earlier drop.
Q2 earnings beat and guidance affirmed CAVA beat second-quarter revenue and earnings estimates, with same-restaurant sales up 9% and adjusted EBITDA up 30%. It opened 17 net new restaurants and affirmed full-year guidance, showing the growth story is intact and pushing the stock sharply higher.
The earnings beat is the biggest new positive catalyst and confirms the company's fundamentals.
Cyclospora headwinds moderating Jefferies said quarter-to-date trends were better than feared, with cyclospora-related weakness bottoming in mid-to-late July before same-restaurant sales recovered toward mid-single-digit growth. Fears easing removes a cloud over the stock and supports the rebound.
This explains why the earlier negative health-scare pressure reversed and the stock jumped.